Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
20-September-2008 10:08:29 - Amaurosis fugax Amaurosis fugax Classification and external resources The arteries of the choroid and iris. The greater part of the sclera has been removed. ICD-10 G45.3 ICD-9 362.34 DiseasesDB 501 MedlinePlus 000784 eMedicine neuro/480 MeSH D020757 Amaurosis fugax Latin fugax meaning fleeting, Greek amaurosis meaning darkening, dark, or obscure is a transient monocular visual loss.1 Contents 1 Pathophysiology and etiology 1.1 Embolic and hemodynamic origin 1.2 Ocular origin 1.3 Neurologic origin 2 Symptoms 3 Diagnostic evaluation 4 Treatment 5 See also 6 Footnotes Pathophysiology and etiology Prior to 1990, amaurosis fugax could, clinically, be divided into four identifiable symptom complexes, each with its underlying pathoetiology: embolic, hypoperfusion, angiospasm, and unknown.2 In 1990, the causes of amaurosis fugax were better refined by Amaurosis Fugax Study Group, which has defined five distinct causes of transient monocular blindness: embolic, hemodynamic, ocular, neurologic, and idiopathic.3 Concerning the pathology underlying these causes stay idiopathic, some of the more frequent causes include atheromatous disease of the internal carotid or ophthalmic artery, vasospasm, optic neuropathies, giant cell arteritis, angle-closure glaucoma, increased intracranial pressure, orbital compressive disease, a steal phenomenon, and blood hyperviscosity or hypercoagulability.4 Embolic and hemodynamic origin With respect to embolic and hemodynamic causes, this transient monocular visual loss ultimately occurs due to a temporary reduction in retinal artery, ophthalmic artery, or ciliary artery blood flow, leading to a decrease in retinal circulation which, in turn, causes retinal hypoxia.5 Also, it must be noted that while, classically and most commonly, emboli causing amaurosis fugax are described as coming from an atherosclerotic carotid artery, any emboli arising from vasculature preceding the retinal artery, ophthalmic artery, or ciliary arteries may cause this transient monocular blindness. Atherosclerotic carotid artery: Amaurosis fugax may present as a type of transient ischemic attack TIA, during which an embolus unilaterally obstructs the lumen of the retinal artery or ophthalmic artery, causing a decrease in blood flow to the ipsilateral retina. The most common source of these athero-emboli is an atherosclerotic carotid artery.6 However, a severely atherosclerotic carotid artery may also cause amaurosis fugax due to its stenosis of blood flow, leading to ischemia when the retina is exposed to bright light.7 Unilateral visual loss in bright light may indicate ipsilateral carotid artery occlusive disease and may reflect the inability of borderline circulation to sustain the increased retinal metabolic activity associated with exposure to bright light.8 Atherosclerotic ophthalmic artery: Will present similarly to an atherosclerotic internal carotid artery. Cardiac emboli: Thrombotic emboli arising from the heart may also cause luminal obstruction of the retinal, ophthalmic, and/or ciliary arteries, causing a decrease in blood flow to the ipsilateral retina; examples being those arising due to 1 atrial fibrillation, 2 valvular abnormalities including post-rheumatic valvular disease, mitral valve prolapse, and a bicuspid aortic valve, and 3 atrial myxomas. Temporary vasospasm leading to decreased blood flow can be a cause of amaurosis fugax.910 Generally, these episodes are brief, lasting no longer that five minutes,11 and have been associated with exercise.512 These vasospastic episodes are not restricted to young and healthy individuals. Observations suggest that a systemic hemodynamic challenge provokes the release of vasospastic substance in the rentinal vasculature of one eye.11 Giant cell arteritis: Giant cell arteritis can result in granulomatous inflammation within the central rentinal artery and posterior ciliary arteries of eye, resulting in partial or complete occlusion, leading to decreased blood flow manifesting as amaurosis fugax. Commonly, amaurosis fugax caused by giant cell arteritis may be associated with jaw claudication and headache. However, it is also not uncommon for these patients to have no other symptoms.13 One comprehensive review found a two to nineteen percent incidence of amaurosis fugax among these patients.14 Systemic lupus erythematosus1516 Periarteritis nodosa17 Eosinophilic vasculitis18 Hyperviscosity syndrome19 Polycythemia20 Hypercoagulability21 Protein C deficiency22 Antiphospholipid antibodies23 Anticardiolipin antibodies24 Lupus anticoagulant2526 Thrombocytosis24 Subclavian steal syndrome Malignant hypertension can cause ischemia of the optic nerve head leading to transient monocular visual loss.27 Drug abuse-related intravascular emboli3 Iatrogenic: Amaurosis fugax can present as a complication following carotid endarterectomy, carotid angiography, cardiac catheterization, and cardiac bypass.24 Ocular origin Ocular causes include: Iritis28 Keratitis19 Blepharitis19 Optic disc drusen24 Posterior vitreous detachment19 Closed-angle glaucoma29 Transient elevation of intraocular pressure328 Intraocular hemorrhage3 Coloboma24 Myopia24 Orbital hemangioma30 Orbital osteoma31 Keratoconjunctivitis sicca24 Neurologic origin Neurological causes include: Optic neuritis3 Compressive optic neuropathies324 Papilledema: The underlying mechanism for visual obscurations in all of these patients appear to be transient ischemia of the optic nerve head consequent to increased tissue pressure. Axonal swelling, intraneural masses, and increased influx of interstitial fluid may all contribute to increases in tissue pressure in the optic nerve head. The consequent reduction in perfusion pressure renders the small, low-pressure vessels that supply the optic nerve head vulnerable to compromise. Brief fluctuations in intracranial or systemic blood pressure may then result in transient loss of function in the eyes.32 Generally, this transient visual loss is also associated with a headache and optic disk swelling. Multiple Sclerosis can cause amaurosis fugax due to a unilateral conduction block, which is a result of demyelination and inflammation of the optic nerve, and ...possibly by defects in synaptic transmission and putative circulating blocking factors.33 Migraine3435363738394041 Pseudotumor cerebri42 Intracranial tumor42 Psychogenic19 Symptoms The experience of amaurosis fugax is classically described as a transient monocular vision loss that appears as a curtain coming down vertically into the field of vision in one eye; however, this altitudinal visual loss is relatively uncommon. In one study, only 23.8 percent of patients with transient monocular vision loss experienced the classic curtain or shade descending over their vision.43 Other descriptions of this experience include a monocular blindness, dimming, fogging, or blurring.44 Total or sectorial vision loss typically lasts only a few seconds, but may last minutes or even hours. Duration depends on the etiology of the vision loss. Obscured vision due to papilledema may last only seconds, while a severely atherosclerotic carotid artery may be associated with a duration of one to ten minutes.45 Certainly, additional symptoms may be present with the amaurosis fugax, and those findings will depend on the etiology of the transient monocular vision loss. Diagnostic evaluation Despite the temporary nature of the vision loss, those experiencing amaurosis fugax are usually advised to consult a physician immediately as it is a symptom that usually heralds serious vascular events, including stroke.4647 Restated, because of the brief interval between the transient event and a stroke or blindness from temporal arteritis, the workup for transient monocular blindness should be undertaken without delay. If the patient has no history of giant cell arteritis, the probability of vision preservation is high; however, the chance of a stroke reaches that for a hemispheric TIA. Therefore, investigation of cardiac disease is justified.3 A diagnostic evaluation should begin with the patient's history, followed by a physical exam, with particular importance being paid to the ophthalmic examination with regards to signs of ocular ischemia. When investigating amaurosis fugax, an ophthalmologic consult is absolutely warranted if available. Several concomitant laboratory tests should also be ordered to investigate some of the more common, systemic causes listed above, including a complete blood count, erythrocyte sedimentation rate, lipid panel, and blood glucose level. If a particular etiology is suspected based on the history and physical, additional relevant labs should be ordered.3 If laboratory tests are abnormal, a systemic disease process is likely, and, if the ophthalmologic examination is abnormal, ocular disease is likely. However, in the event that both of these routes of investigation yield normal findings, or an inadequate explanation, noninvasive duplex ultrasound studies are recommended to identify carotid artery disease. Most episodes of amaurosis fugax are the result of stenosis of the ipsilateral carotid artery.48 With that being the case, researchers investigated how best to evaluate these episodes of vision loss, and concluded that for patients ranging from 36-74 years old, ...carotid artery duplex scanning should be performed...as this investigation is more likely to provide useful information than an extensive cardiac screening ECG, Holler 24-hour monitoring and precordial echocardiography.48 Additionally, concomitant head CT or MRI imaging is also recommended to investigate the presence of a clinically silent cerebral embolism.3 If the results of the ultrasound and intracranial imaging are normal, renewed diagnostic efforts may be made, during which fluorescein angiography is an appropriate consideration. However, carotid angiography is not advisable in the presence of a normal ultrasound and CT.49 Treatment If the diagnostic workup reveals a systemic disease process, directed therapies to treat that underlying etiology should be initiated. If the amaurosis fugax is caused by an atherosclerotic lesion, aspirin is indicated, and a carotid endarterectomy if the stenosis is surgically accessible. Generally, if the carotid artery is still patent, the greater the stenosis, the greater the indication for endarterectomy. Amaurosis fugax appears to be a particularly favorable indication for carotid endarterectomy. Left untreated, this event carries a high risk of stroke; after carotid endarterectomy, which has a low operative risk, there is a very low postoperative stroke rate.50 If the full diagnostic workup is completely normal, patient observation is recommended.3 See also Ocular ischemic syndrome Amaurosis Footnotes ^ Fisher, C. 'Transient monocular blindness' versus 'amaurosis fugax.' Neurology. 1989;3912:1622-4. PMID 2685658. ^ Burde RM. Amaurosis fugax. An overview. J Clin Neuroophthalmol. 1989 Sep;93:185-9. PMID 2529279 ^ a b c d e f g h i j The Amaurosis Fugax Study Group. Current management of amaurosis fugax. Stroke. 1990;212:201-208. ^ Newman NJ. Cerebrovascular disease. Walsh Hoyt's Clinical Neuro-Ophthalmology. Miller NR, Newman NJ, eds. Vol 3. 5th ed. Baltimore, Williams Wilkins; 1998:3420-3426. ^ a b Exercise-Induced Vasospastic Amaurosis Fugax. Arch Ophthalmol. 2002 February;1202:220-222. ^ Braat, Andries; Peter H. Hoogland, A.C. DeVries, J.C. Alexander de Mol VanOtterloo. Amaurosis Fugax and Stenosis of the Ophthalmic Artery. Vascular and Endovascular Surgery. 2001;352:141-142. ^ Kaiboriboon K; Piriyawat P; Selhorst JB. Light-induced amaurosis fugax. Am J Ophthalmol. 2001 May;1315:674-6. PMID 11336956. ^ AU Furlan AJ; Whisnant JP; Kearns TP. Unilateral visual loss in bright light. An unusual symptom of carotid artery occlusive disease. Arch Neurol. 1979 Nov;3611:675-6. PMID 508123. ^ Ellenberger C Jr., Epstein AD. Ocular complications of atherosclerosis: what do they mean? Semin Neurol. 1986;6:185-193. ^ Fisher M. Transient monocular blindness associated with hemiplegia. Arch Ophthalmol. 1952;47:167-203. ^ a b Burger, Stephen; robert Saul, John Selhorst, Stephen Thurston. Transient monocular blindness caused by vasospasm. The New England Journal of Medicine. 1991;325:870-873. ^ Imes RK, Hoyt WF. Exercise-induced transient visual events in young healthy adults. J Clin Neuro Ophthalmol. 1989:9;9:178-180. ^ AU Hayreh SS; Podhajsky PA; Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998 Apr;1254:521-6. PMID 9559738. ^ Goodman BW Jr. Temporal arteritis. Am J Med. 1979;67:839-852. ^ Giorgi, Afeltra, Gabrieli. Transient visual symptoms in systemic lupus erthematosus and antiphospholipid syndrome. Ocular Immunology and Inflammation. March 2001;91:49-57. ^ Gold D, Feiner L, Henkind P. Retinal arterial occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1977;95:1580-1585. ^ Newman NM, Hoyt WF, Spencer WH. Macula-sparing blackouts: clinical and pathologic investigations of intermittent choroidal vascular insufficiency in a case of periarteritis nodosa. Arch Ophthalmol. 1974; 91:367-370. ^ Schwartz ND, So YT, Hollander H, Allen S, Fye KH. Eosinophilic vasculitis leading to amaurosis fugax in a patient with acquired immunodeficiency syndrome. Arch Intern Med. 1986;146:2059-2060 ^ a b c d e Bacigalupi, Michael. Amaurosis Fugax-A Clinical Review. The Internet Journal of Allied Health Sciences and Practice. April 2006;42:1-6. ^ Berdel, Theiss, Fink, Rastetter. Peripheral arterial occlusion and amaurosis fugax as the first manifestation of polycythemia vera. Journal Annals of Hematology. 1984;483:177-180. ^ Mundall, Quintero, von Kaulla, Harmon, Austin. Transient monocular blindness and increased platelet aggregability treated with aspirin. Neurology. 1972;22:280-285. ^ Smith. Protein C deficiency: A cause of amaurosis fugax? Neurol Neurosurg Psychiatry. 1987;50:361-362. ^ Digre, Durcan, Branch, Jacobson, Varner, Baringer. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol. 1989;25:228-232. ^ a b c d e f g h Digre, Kathleen. Amaurosis Fugax and Not So Fugax-Vascular Disorders of the Eye. Practical Viewing of the Optic Disc. Butterworth Heinemann: November 2002:269-344. ^ Landi, Calloni, Sabbadini, Mannucci, Candelise. Recurrent ischemic attacks in two young adults with lupus anticoagulants. Stroke. 1983;14:377-379. ^ Elias M, Eldor A. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. arch Intern Med. 1984;144:510-515. ^ Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension, V. hypertensive optic neuropathy. Ophthalmology. 1986;93:74-87. ^ a b Sorensen PN. Amaurosis fugax. A unselected material. Acta Ophthalmol Copenh. 1983 Aug;614:583-8. PMID: 6637419. ^ Ravits J, Seybold M. Transient monocular visual loss from narrow-angle glaucoma. Arch Neurol. 1984;41:991-993. ^ Brown GC, Shields JA. Amaurosis fugax secondary to presumed cavernous hemangioma of the orbic. Ann Ophthalmol. 1981;13:1205-12O9. ^ Wilkes SR, Troutmann JC, DeSanto LW, Campbell RJ. Osteoma. An unusual cause of amaurosis fugax. Mayo Clin Proc. 1979;54:258-260. ^ AU Hayreh SS; Podhajsky PA; Zimmerman B. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984 Oct;164:489-94. PMID 6497356. ^ AU Smith KJ; McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci. 1999 October 29;3541390:1649-73. PMID 10603618. ^ Mattsson, Lundberg. Characteristics and prevalence of transient visual disturbances indicative of migraine visual aura. Cephalalgia. June 1999;195:447. ^ Cologno, Torelli, Manzoni. Transient vidual disturbances during migraine without aura attacks. Headache. October 2002;429:930-933. ^ Connor RCR. Complicated migraine: A study of permanent neurological and visual defects caused by migraine. Lancet. 1962;2:1072-1075. ^ Carroll D. Retinal migraine. Headache. 1970;10:9-13. ^ McDonald WI, Sanders MD. Migraine complicated by ischemic papillopathy. Lancet. 1971;2:521-523. ^ Wolter JR, Burchfield WJ. Ocular migraine in a young man resulting in unilateral transient blindness and retinal edema. Pediatr Ophthalmol. 1971;8:173-176. ^ Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980;20:253-257. ^ Corbett JJ. Neuro-ophthalmologic complications of migraine and cluster headaches. Neurol Clin. 1983;l:973-995. ^ a b Hedges, Thomas. The Terminology of Transient Visual Loss Due to Vascular Insufficiency. Stroke. 1984; 155:907-908. ^ Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 August 15;3257:445-53. PMID 1852179. ^ Lord RS. Transient monocular blindness. Aust N Z J Ophthalmol. 1990 Aug;183:299-305. PMID 2261177. ^ Donders RC. Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery. J Neurol Neurosurg Psychiatry. 2001 Aug;712:247-9. PMID 11459904. ^ Benavente, Eliasziw, Steifler, Fox, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med. 2001;34515:1084-1090. ^ Rothwell, Warlow. Timing of TIA's preceding stroke: time window for prevention is very short. Neurology. 2005;64:817. ^ a b Smit, Ronald; G. Seerp Baarsma and Peter J. Koudstaal The source of embolism in amaurosis fugax and retinal artery occlusion. International Ophthalmology. 1994 March;182:83-86. ISSN 0165-5701. ^ Walsh J, Markowitz I, Kerstein MD. Carotid endarterectomy for amaurosis fugax without angiography. Am J Surg. 1986 Aug;1522:172-4. PMID 3526933. ^ Bernstein EF, Dilley RB. Late results after carotid endarterectomy for amaurosis fugax. J Vasc Surg. 1987 Oct;64:333-40. PMID 3656582. v d e Pathology of the nervous system, primarily CNS G00-G47, 320-349 Inflammatory Meningitis Arachnoiditis - Encephalitis - Myelitis - Encephalomyelitis Acute disseminated - Tropical spastic paraparesis - Cavernous sinus thrombosis Systemic atrophies Huntington's disease - Spinocerebellar ataxia Friedreich's ataxia, Ataxia telangiectasia, Herary spastic paraplegia - Spinal muscular atrophy: Werdnig-Hoffman - Kugelberg-Welander - Fazio-Londe - MND ALS, PMA, PBP, PP, PLS Extrapyramidal and movement disorders Parkinson's disease - Neuroleptic malignant syndrome - Postencephalitic parkinsonism - Pantothenate kinase-associated neurodegeneration - Progressive supranuclear palsy - Striatonigral degeneration - Dystonia/Dyskinesia Spasmodic torticollis, Meige's, Blepharospasm - Essential tremor - Myoclonus - Lafora - Chorea Choreoathetosis - Restless legs - Stiff person Other degenerative/ demyelinating diseases dementia: Alzheimer's - Pick's - Dementia with Lewy bodies - Frontotemporal lobar degeneration mitochondrial disease: Leigh's demyelinating: Multiple sclerosis - Devic's - Central pontine myelinolysis - Transverse myelitis - Marchiafava-Bignami disease - CAMFAK syndrome - Alpers' Seizure/epilepsy Focal - Generalised - Status epilepticus - Myoclonic epilepsy Headache Migraine Familial hemiplegic - Cluster - Vascular - Tension Vascular Transient ischemic attack Amaurosis fugax, Transient global amnesia Cerebrovascular disease MCA, ACA, PCA, Foville's, Millard-Gubler, Lateral medullary, Weber's, Lacunar stroke Sleep disorders Insomnia - Hypersomnia - Sleep apnea Obstructive, Ondine's curse - Narcolepsy - Cataplexy - Kleine-Levin - Circadian rhythm sleep - Delayed sleep phase - Advanced sleep phase Intracranial hypertension Hydrocephalus Normal pressure - Idiopathic intracranial hypertension Other encephalopathy Brain herniation - Cerebral edema - Reye's Other spinal cord disease Syringomyelia - Syringobulbia - Morvan's syndrome - Spinal cord compression Retrieved from http://en..org/wiki/Amaurosis_fugax Categories: Cardiovascular diseases | Ophthalmology | Neurology | Symptoms Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages Deutsch Italiano Polski 中文 This page was last modified on 11 August 2008, at 19:10
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.